Ensitrelvir Demonstrates Effectiveness in Preventing COVID-19 as Post-Exposure Prophylaxis: Results from the SCORPIO-PEP Phase 3 Trial SCORPIO-PEP Phase 3: Ensitrelvir First Oral Antiviral to Prevent COVID-19 as Post-Exposure Prophylaxis At the Conference on Retroviruses and Opportunistic Infections 2025, Shionogi &…
Oligomerix Publishes Preclinical Results of Oral Alzheimer’s Drug Study Oligomerix, Inc., a pioneering clinical-stage biotechnology company focused on developing protein self-association inhibitors for Alzheimer’s disease (AD) and related neurodegenerative disorders, has announced the publication of a preclinical study demonstrating the…
ARM & HAMMER Baking Soda Joins the 2025 STEM Festival to Ignite Curiosity in STEAM ARM & HAMMER Baking Soda is gearing up for an exciting and impactful presence at the 2025 STEM Festival, committed to supporting its mission of…
Free Heart & Kidney Health Screenings Available in Jacksonville, March 17-19 Care Access, a leading health and research organization, is offering free Heart & Kidney Community Health Screenings to Jacksonville residents from March 17-19. These screenings are part of an…
InTandem Capital Partners Invests in Clinilabs to Accelerate CNS Drug and Device Development InTandem Capital Partners, a private equity firm specializing in healthcare services, has announced a strategic partnership with Clinilabs, a global full-service contract research organization (CRO). This collaboration…
LGM Pharma Invests Over $6M to Expand U.S. Manufacturing Facility in Texas LGM Pharma, a leading provider of tailored Active Pharmaceutical Ingredient (API) and Contract Development and Manufacturing Organization (CDMO) services for the full drug product lifecycle, has announced a…
IQVIA Recognized as a Leader in IDC MarketScape’s 2024 Assessment for Decentralized Clinical Trial Technologies and Consulting Services IQVIA, a global leader in AI-powered analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, has been…
Ventus Therapeutics Doses First Patient in Phase 2a Trial of VENT-02 for Parkinson’s Disease Ventus Therapeutics, a clinical-stage biopharmaceutical company, has announced that the first patient has been dosed in its Phase 2a clinical trial evaluating VENT-02 in patients with…
Evonik Expands Defoamer Range with TEGO® Foamex 8420 for Waterborne Inks and Varnishes Evonik Coating Additives has expanded its portfolio of high-performance defoamers for waterborne formulations with the launch of TEGO® Foamex 8420. Designed to tackle the most demanding defoaming…
DuPont Water Solutions Launches WAVE PRO for Ultrafiltration Modeling DuPont Water Solutions has introduced WAVE PRO, an advanced online modeling tool designed to optimize ultrafiltration (UF) water treatment applications. This tool is applicable across a range of water treatment needs,…
Dow Invests in Advanced Recycling Startup Xycle to Boost Circular Feedstock Access In a strategic move to further its commitment to transforming waste and advancing a circular economy for plastics, Dow has made an equity investment in Xycle, a Rotterdam-based…
Natera Announces Enrollment of First Patients in HEROES Clinical Trial for Metastatic HER2+ Breast Cancer Natera, Inc., a leader in cell-free DNA and genetic testing, has announced the enrollment of the first patients in the HEROES clinical trial. This pivotal…